PMID: 42576909

Mitochondria-targeted peptide-engineered bimetallic nanozymes enable ferroptosis-sensitized cuproptosis for melanoma therapy.

Kong Jiahui, Cai Mengru, Sun Ao, Zhao Mengdi, Li Mengqian, Wang Xiaomeng, Qiao Jiaxin, Bao Huizhong, Zhao Ranran, Xu Bing

Materials today. Bio · 2026

Vol. 40, pp. 103486

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.